Eagle Hitomi Technology-B (02251) announced results for the year ended December 31, 2023. The group achieved...
According to the Zhitong Finance App, Eagle Hitomi Technology-B (02251) announced results for the year ended December 31, 2023. The group achieved revenue of 204 million yuan (RMB, same below) during the period, an increase of 79.46%; parent company owners should have accounted for a loss of 133 million yuan, a year-on-year decrease of 26.37%; and a basic loss of 1.28 yuan per share.
In 2023, the Group served a total of 6.83 million cases and identified 31,459 major positive cases through SaMD and health risk assessment solutions. The number of active service outlets increased to 5671, an increase of 139.2% year on year, and the number of customers increased to 673, an increase of 69.5% year on year.
The Group has sold AirDoc-aifundus (1.0) to hospitals and primary care institutions, and there has been a significant increase in the number of outlets and tests. Among them, the number of active outlets covered by hospitals reached 276, an increase of 527.3% over the previous year; the number of tests reached 242,000, an increase of 197.5% over the previous year. The number of active outlets covered by primary medical institutions reached 1,221, an increase of 1271.9% over the previous year; the number of tests reached 635,000, an increase of 640.2% over the previous year.